Hyperthermia-augmented epithelial apoptosis and acute lung injury

热疗增强上皮细胞凋亡和急性肺损伤

基本信息

  • 批准号:
    8974334
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lung epithelium is critical to normal gas exchange and maintenance of a physical and immu- nologic barrier against environmental dangers. Acute loss of epithelium can have devastating consequences, including loss of gas exchange, surfactant synthesis, airway obstruction, and increased susceptibility to secondary infections. The processes that regulate epithelial cell sur- vival are critical to how lung epithelium responds to acute and chronic environmental challenges with important consequences for lung function and host survival. We have identified new path- ways by which hyperthermia, such as occurs in fever, clinical hyperthermia syndromes and en- vironmental exposures, accelerate apoptosis in lung epithelium and worsen lung injury. The overall objective of this application is to elucidate the mechanisms by which hyperthermia within the febrile range modifies lung epithelial injury and recovery. Our central hypothesis is that ex- posure to hyperthermia concurrent with activation of death receptors (e.g. TNF Receptor- 1/TNFR1 or fas) accelerates assembly of the death inducing signaling complexes, augments downstream pro-apoptotic pathways, and inhibits anti-apoptotic factors. The rationale for our hypothesis is based on our recent studies demonstrating that (1) co-exposure to hyperthermia in the HS (42C) or febrile (39.5C) range greatly increases and accelerates caspase-3 activation and apoptosis in mouse MLE15 lung epithelial cells after TNF treatment or fas activation and is independent of NFB and the major heat activated transcription factor, HSF-1, and (2) there is a limited time window following TNF treatment but not fas activation after which cells are pro- tected from HS-augmented apoptosis (discussed in the Preliminary Data section). We will utilize MLE-15 mouse lung epithelial cells, BEAS2B human lung epithelial cells, and primary cultured human small airway epithelial cells (SAECs), and an in vivo intratracheal LPS-induced mouse ALI model to pursue the following specific aims: (1) determine how hyperthermia alters TNF- and fas-activated death-inducing signaling complexes, their composition, and function and the consequences for cell survival vs. death; (2) delineate the effect of hyperthermia on JNK MAP kinase signaling and the consequences for cells survival vs. death in cells TNF-treated cells; (3) analyze the mechanisms of hyperthermia-enhanced apoptosis in human lung epithelial cells, and (4) analyze the contribution of accelerated epithelial apoptosis to LPS-induced lung injury. We expect that the results of the proposed studies will identify new pathophysiologic pathways that contribute to lung injury under clinically relevant conditions. The pharmacologic studies in aim 4 will provide new preclinical data that may lead to future therapies in patients with ALI.
描述(由申请人提供): 肺上皮对于正常气体交换和维持应对环境危险的物理和免疫性障碍至关重要。上皮的急性损失可能会带来毁灭性的后果,包括气体交换,表面活性剂合成,气道阻塞以及对继发感染的易感性增加。调节上皮细胞表面的过程对于肺上皮如何应对急性和慢性环境挑战至关重要,对肺功能和宿主存活产生了重要影响。我们已经确定了高温(例如发烧,临床高温综合征和环境暴露),肺上皮凋亡加速并加速肺损伤的新路径。该应用的总体目的是阐明高热范围内的高温修饰肺上皮损伤和恢复的机制。我们的中心假设是,与激活死亡受体(例如TNF受体1/TNFR1或FAS)同时发生的高温可加速死亡诱导信号传导复合物的组装,增强下游促凋亡途径,并抑制抗吞噬因素。我们的假设的理由是基于我们最近的研究,表明(1)HS(42C)或高温(39.5C)在HS(42C)或高温(39.5C)中的共同曝光范围很大,caspase-3的激活和凋亡加速了小鼠MLE15小鼠MLE15肺上皮细胞在TNF治疗或FAS激活和NFB的肺上皮细胞中,并具有独立的NFB和IS nfb的主要因素,并且是主要的HEFB,并且是主要的HEFB,并且是主要的HEFB和IS a ISTRACTION HEFB,主要是HEFB,并且是IS nfb的主要因素,并且是主要的HEFB和INFB的主要因素。 (2)TNF处理后有一个有限的时间窗口,但没有FAS激活,然后从HS-EAGENT的细胞凋亡中调查细胞(在初步数据部分中进行了讨论)。 We will utilize MLE-15 mouse lung epithelial cells, BEAS2B human lung epithelial cells, and primary cultured human small airway epithelial cells (SAECs), and an in vivo intratracheal LPS-induced mouse ALI model to pursue the following specific aims: (1) determine how hyperthermia alters TNF- and fas-activated death-inducing signaling complexes, their composition, and function and细胞生存与死亡的后果; (2)描述高温对JNK MAP激酶信号传导的影响以及细胞与细胞中TNF处理的细胞中生存的后果; (3)分析人肺上皮细胞中高温增强细胞凋亡的机制,(4)分析加速上皮凋亡对LPS诱导的肺损伤的贡献。我们预计拟议的研究的结果将确定在临床相关条件下导致肺损伤的新的病理生理途径。 AIM 4中的药理学研究将提供新的临床前数据,这些数据可能会导致ALI患者的未来疗法。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
(1Z,1'Z,3E,3'E)-1,1'-Diphenyl-3,3'-[(1S,2S)-cyclo-hexane-1,2-diyldinitrilo]dibut-1-en-1-ol.
(1Z,1Z,3E,3E)-1,1-二苯基-3,3-[(1S,2S)-环己烷-1,2-二基二氮基]二丁-1-en-1
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY D HASDAY其他文献

JEFFREY D HASDAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY D HASDAY', 18)}}的其他基金

Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome
开发新型第二代抗炎底物选择性 p38 MAP 激酶抑制剂治疗急性呼吸窘迫综合征
  • 批准号:
    10535453
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome
开发新型第二代抗炎底物选择性 p38 MAP 激酶抑制剂治疗急性呼吸窘迫综合征
  • 批准号:
    10367545
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Hyperthermia-augmented epithelial apoptosis and acute lung injury
热疗增强上皮细胞凋亡和急性肺损伤
  • 批准号:
    8542278
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Hyperthermia-augmented epithelial apoptosis and acute lung injury
热疗增强上皮细胞凋亡和急性肺损伤
  • 批准号:
    8721706
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Novel Mechanisms of Smooth Muscle Beta2-receptor Regulation Relevant to Asthma
与哮喘相关的平滑肌β2受体调节新机制
  • 批准号:
    8661247
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
The contribution of heat shock/stress pathways to acute lung injury
热休克/应激途径对急性肺损伤的影响
  • 批准号:
    7264065
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
The contribution of heat shock/stress pathways to acute lung injury
热休克/应激途径对急性肺损伤的影响
  • 批准号:
    7386621
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
The contribution of heat shock/stress pathways to acute lung injury
热休克/应激途径对急性肺损伤的影响
  • 批准号:
    7586229
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
The contribution of heat shock/stress pathways to acute lung injury
热休克/应激途径对急性肺损伤的影响
  • 批准号:
    7780051
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Mechanisms of HSF1-mediated Repression of TNF-alpha
HSF1 介导的 TNF-α 抑制机制
  • 批准号:
    6875575
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
  • 批准号:
    82360379
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
  • 批准号:
    82374186
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
  • 批准号:
    82302445
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
  • 批准号:
    82374400
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目

相似海外基金

The role of amphiregulin in mediating radiation cystitis in cancer survivors
双调蛋白在介导癌症幸存者放射性膀胱炎中的作用
  • 批准号:
    10636699
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Characterizing chemical threat agent exposures using a lung-on-a-chip platform and multi-omic analysis of common pathophysiological mechanisms
使用芯片肺平台和常见病理生理机制的多组学分析来表征化学威胁剂暴露
  • 批准号:
    10708553
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas Injury
眼芥子气损伤的组织缺氧和局部氧疗
  • 批准号:
    10630652
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The Role of Lipids in Obesity-mediated Protection in Sepsis
脂质在肥胖介导的脓毒症保护中的作用
  • 批准号:
    10729051
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了